6 results
8-K
EX-10.1
MLYS
Mineralys Therapeutics Inc
8 Feb 24
Mineralys Therapeutics Announces $120 Million Private Placement Financing
4:41pm
, that there may be a conflict of interest between the positions of the indemnifying party and the indemnified party in conducting the defense of any such action
DRS/A
MLYS
Mineralys Therapeutics Inc
29 Dec 22
Draft registration statement (amended)
12:00am
authority may conclude that a financial relationship between us and a principal investigator has created a conflict of interest or otherwise affected
DRS/A
MLYS
Mineralys Therapeutics Inc
7 Dec 22
Draft registration statement (amended)
12:00am
between us and a principal investigator has created a conflict of interest or otherwise affected interpretation of the study. The FDA or comparable foreign
DRS
MLYS
Mineralys Therapeutics Inc
4 Nov 22
Draft registration statement
12:00am
or comparable foreign regulatory authority may conclude that a financial relationship between us and a principal
- 19 -
investigator has created a conflict … of interest or otherwise affected interpretation of the study. The FDA or comparable foreign regulatory authority may therefore question
DRS
EX-4.2
ku9uwxvs2h5urshegq
4 Nov 22
Draft registration statement
12:00am
- Prev
- 1
- Next